Literature DB >> 17392278

Specificity profiling of Pak kinases allows identification of novel phosphorylation sites.

Ulrike E E Rennefahrt1, Sean W Deacon, Sirlester A Parker, Karthik Devarajan, Alexander Beeser, Jonathan Chernoff, Stefan Knapp, Benjamin E Turk, Jeffrey R Peterson.   

Abstract

The p21-activated kinases (Paks) serve as effectors of the Rho family GTPases Rac and Cdc42. The six human Paks are divided into two groups based on sequence similarity. Group I Paks (Pak1 to -3) phosphorylate a number of substrates linking this group to regulation of the cytoskeleton and both proliferative and anti-apoptotic signaling. Group II Paks (Pak4 to -6) are thought to play distinct functional roles, yet their few known substrates are also targeted by Group I Paks. To determine if the two groups recognize distinct target sequences, we used a degenerate peptide library method to comprehensively characterize the consensus phosphorylation motifs of Group I and II Paks. We find that Pak1 and Pak2 exhibit virtually identical substrate specificity that is distinct from that of Pak4. Based on structural comparisons and mutagenesis, we identified two key amino acid residues that mediate the distinct specificities of Group I and II Paks and suggest a structural basis for these differences. These results implicate, for the first time, residues from the small lobe of a kinase in substrate selectivity. Finally, we utilized the Pak1 consensus motif to predict a novel Pak1 phosphorylation site in Pix (Pak-interactive exchange factor) and demonstrate that Pak1 phosphorylates this site both in vitro and in cultured cells. Collectively, these results elucidate the specificity of Pak kinases and illustrate a general method for the identification of novel sites phosphorylated by Paks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392278     DOI: 10.1074/jbc.M700253200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Pak1 regulates branching morphogenesis in 3D MDCK cell culture by a PIX and beta1-integrin-dependent mechanism.

Authors:  Michael P Hunter; Mirjam M Zegers
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-24       Impact factor: 4.249

2.  Phosphoinositides are essential coactivators for p21-activated kinase 1.

Authors:  Todd I Strochlic; Julien Viaud; Ulrike E E Rennefahrt; Theonie Anastassiadis; Jeffrey R Peterson
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

Review 3.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 4.  Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.

Authors:  Yang-Guang Shao; Ke Ning; Feng Li
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 5.  Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.

Authors:  Byung Hak Ha; Elizabeth M Morse; Benjamin E Turk; Titus J Boggon
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

Review 6.  Understanding and exploiting substrate recognition by protein kinases.

Authors:  Benjamin E Turk
Journal:  Curr Opin Chem Biol       Date:  2008-03-07       Impact factor: 8.822

7.  ArhGAP15, a Rac-specific GTPase-activating protein, plays a dual role in inhibiting small GTPase signaling.

Authors:  Maria Radu; Sonali J Rawat; Alexander Beeser; Anton Iliuk; Weiguo Andy Tao; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

8.  Maturin is a novel protein required for differentiation during primary neurogenesis.

Authors:  Reyna I Martinez-De Luna; Ray Yueh Ku; Yung Lyou; Michael E Zuber
Journal:  Dev Biol       Date:  2013-10-01       Impact factor: 3.582

Review 9.  Homing in: Mechanisms of Substrate Targeting by Protein Kinases.

Authors:  Chad J Miller; Benjamin E Turk
Journal:  Trends Biochem Sci       Date:  2018-03-12       Impact factor: 13.807

10.  The human kinome and kinase inhibition.

Authors:  Krisna C Duong-Ly; Jeffrey R Peterson
Journal:  Curr Protoc Pharmacol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.